<ARTICLE>                     5
<CIK>                         0000880771
<NAME>                        SCICLONE PHARMACEUTICALS, INC.
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   MAR-31-1996
<CASH>                                         3,892,265
<SECURITIES>                                  41,295,661
<RECEIVABLES>                                  1,882,788
<ALLOWANCES>                                           0
<INVENTORY>                                    2,532,746
<CURRENT-ASSETS>                              21,159,051
<PP&E>                                           850,575
<DEPRECIATION>                                  (532,227)
<TOTAL-ASSETS>                                52,249,193
<CURRENT-LIABILITIES>                          4,378,754
<BONDS>                                                0
<COMMON>                                     108,267,851
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<OTHER-SE>                                   (60,397,412)
<TOTAL-LIABILITY-AND-EQUITY>                  52,249,193
<SALES>                                          126,308
<TOTAL-REVENUES>                                 126,308
<CGS>                                            199,800
<TOTAL-COSTS>                                    199,800
<OTHER-EXPENSES>                               4,381,116
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                     0
<INCOME-PRETAX>                               (3,738,502)
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                           (3,738,502)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                  (3,738,502)
<EPS-PRIMARY>                                       (.22)
<EPS-DILUTED>                                          0